Profund Advisors’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.14M	Buy	89,055 +9,391	+12%	+$120K	0.04%	316
2025 Q4	$716K	Buy	79,664 +40,078	+101%	+$552K	0.02%	444
2025 Q3	$684K	Buy	39,586 +12,084	+44%	+$149K	0.02%	423
2025 Q2	$258K	Sell	27,502 -10,032	-27%	-$82.4K	0.01%	775
2025 Q1	$267K	Sell	37,534 -11,589	-24%	-$117K	0.01%	740
2024 Q4	$573K	Sell	49,123 -1,229	-2%	-$19.2K	0.02%	444
2024 Q3	$1.03M	Buy	50,352 +11,405	+29%	+$263K	0.04%	315
2024 Q2	$872K	Sell	38,947 -9,353	-19%	-$223K	0.03%	336
2024 Q1	$1.33M	Sell	48,300 -2,676	-5%	-$74.3K	0.05%	277
2023 Q4	$1.55M	Buy	50,976 +10,515	+26%	+$302K	0.07%	238
2023 Q3	$1.28M	Buy	40,461 +4,592	+13%	+$178K	0.07%	232
2023 Q2	$1.46M	Sell	35,869 -269	-0.7%	-$10.9K	0.08%	218
2023 Q1	$1.35M	Buy	36,138 +24,603	+213%	+$965K	0.08%	215
2022 Q4	$402K	Buy	11,535 +1,458	+14%	+$69.3K	0.03%	497
2022 Q3	$564K	Buy	10,077 +412	+4%	+$25.6K	0.04%	356
2022 Q2	$500K	Sell	9,665 -1,021	-10%	-$51.8K	0.03%	412
2022 Q1	$777K	Sell	10,686 -1,191	-10%	-$101K	0.03%	380
2021 Q4	$1.4M	Sell	11,877 -1,221	-9%	-$153K	0.05%	253
2021 Q3	$1.76M	Buy	13,098 +11,222	+598%	+$1.7M	0.06%	242
2021 Q2	$303K	Buy	+1,876	New	+$146K	0.01%	1054